(PharmaNewsWire.Com, May 10, 2017 ) According to Publisher, the Global Medical Disposables Market is accounted for $178.37 billion in 2015 and is expected to reach $267.96 billion by 2022 growing at a CAGR of 5.9%. In the present scenario healthcare advancement in techniques and new care products are hovering over the market. Rising geriatric population and more occurrence of chronic disease which need utmost care in hospitals are the reasons behind the growth of the market. Moreover stringent FDA and GMP approval norms which reduce the infection case are going to curb the market.
Hospital segment among the end-users is anticipated to grow at exponential pace led by the rising admissions in hospitals owing to more no: of patients. Moreover medical disposables in product segment are expected to grow at a strong pace because of more people visiting hospitals for regular checkups, surgeries and patient admissions. North America is estimated to be the largest market, as it inherited advanced healthcare very early and Asia Pacific is expected to grow at a rapid pace because of recent advancements in healthcare and more amount of aging population.
Some of the Key players of the market are B. Braun Melsungen AG, Halyard Health Incorporated, Domtar Corporation, Roche Diagnostics Corporation, Abbott Diabetes Care Inc.,, Bayer Healthcare AG, Johnson & Johnson, 3M Company, Smith & Nephew plc , SCHOTT AG, Ahlstrom Corporation , Becton Dickinson, and Company, Terumo Corporation, Kimberly-Clark Corporation, Medtronic plc, STERIS Corporation, Baxter International Incorporated, Halyard Health Incorporated and Covidien Plc.
End-Users Covered: -Home healthcare facilities -Outpatient facilities -Emergency care -Hospitals -Physician offices Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
Company Profiling 9.1 B. Braun Melsungen AG, 9.2 Halyard Health Incorporated 9.3 Domtar Corporation 9.4 Roche Diagnostics Corporation 9.5 Abbott Diabetes Care Inc., 9.6 Bayer Healthcare AG 9.7 Johnson & Johnson 9.8 3M Company 9.9 Smith & Nephew plc 9.10 SCHOTT AG 9.11 Ahlstrom Corporation 9.12 Becton Dickinson, and Company 9.13 Terumo Corporation 9.14 Kimberly-Clark Corporation 9.15 Medtronic plc 9.16 STERIS Corporation 9.17 Baxter International Incorporated 9.18 Halyard Health Incorporated 9.19 Covidien Plc
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
